Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997Ian W Flinn, Donna S Neuberg, Michael R Grever, et al.
Leukemia Research|August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) studyAthena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)Peter L Greenberg, Sandra J Lee, Ranjana Advani, et al.
Journal of Medicinal Chemistry|March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine BioisosteresYoung-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl CoreYoung-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
The New England Journal of Medicine|September 25, 2009
Anthracycline dose intensification in acute myeloid leukemiaHugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based reviewDenise M Oliansky, Joseph H Antin, John M Bennett, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial TargetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Cell Chemical Biology|August 13, 2024
Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targetsJohn M Bennett, Sunil K Narwal, Stephanie Kabeche, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
Pageof 14